Aloe Based Compositions Comprising Polysaccharides and Polyphenols for Regulation of Homeostasis of Immunity

US2022016196A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022016196-A1
Application numberUS-202117370200-A
CountryUS
Kind codeA1
Filing dateJul 8, 2021
Priority dateJul 9, 2020
Publication dateJan 20, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions used and methods are disclosed for regulation of immunity homeostasis including a combination of an Aloe extract enriched for one or more polysaccharides; a Poria extract enriched for one or more polysaccharides; and a Rosemary extract enriched for one or more polyphenolic compounds. Compositions for maintenance of immunity homeostasis by regulating HMGB1, comprising a combination of one or more polysaccharides and one or more polyphenolic compounds are disclosed. Methods for treating, managing, promoting regulation of immunity homeostasis in a mammal are disclosed that include administering an effective amount of a composition from 0.01 mg/kg to 500 mg/kg body weight of the mammal.

First claim

Opening claim text (preview).

1 . A composition for regulation of immunity homeostasis, comprising a combination of an Aloe extract enriched for one or more polysaccharides; a Poria extract enriched for one or more polysaccharides; and a Rosemary extract enriched for one or more polyphenolic compounds. 2 . The composition of claim 1 , wherein the Aloe extract, or Poria extract or Rosemary extract in the composition is in a range of 1%-98% by weight of each extract with the optimized weight ratio of Aloe:Poria:Rosemary (APR) at 3:2:1 (50%:33.3%:16.7%) or 1:1:1 (33.3%:33.3%:33.3%) or 3:6:1 (30%:60%:10%). 3 . The composition of claim 1 , wherein the Aloe extract is whole leaf gel or inner leaf gel from Aloe vera or Aloe barbadense, the Poria extract is from mushroom or fruit body of Poria cocos or Wolfiporia extensa, and Rosemary extract is from leaf of Rosmarinus officinalis. 4 . The composition of claim 1 wherein the Aloe extract comprises 0.01% to 99.9% of polysaccharides. 5 . The composition of claim 1 wherein the Poria extract comprises 0.01% to 99.9% of polysaccharides. 6 . The composition of claim 1 wherein the Rosemary extract comprises 0.01% to 99.9% of Rosmarinic acid. 7 . The composition of claim 1 , wherein the one or more polysaccharides from the Aloe extract is an acetylated polysaccharide or acemannan or any combination thereof. 8 . The composition of claim 1 , wherein the one or more polysaccharides from the Poria extract is a beta-glucan or a combination thereof. 9 . The composition of claim 1 , wherein the one or more polysaccharides are enriched from a plant species selected from the group consisting of or a combination thereof Aloe vera, Aloe barbadense, Aloe ferox, Aloe arborescens, Astragalus membranaceus, Ganoderma lucidum, Hordeum vulgare, Agaricus ( A. blazei ) subrufescens, Echinacea purpurea, Echinacea angustifolia, Aconitum Napellus (Monkshood), Sambucus nigra, Poria cocos Wolf, Wolfiporia extensa, Withania somnifera, Bupleurum falcatum, Glycyrrhiza spp, Panax quinquefolium, Panax ginseng C. A. Meyer, Korea red ginseng, Lentinula edodes (shiitake), Inonotus obliquus ( Chaga mushroom), Lentinula edodes, Lycium barbarum, Lycium chinense, Phellinus linteus (fruit body), Trametes versicolor (fruit body), Cyamopsis tetragonolobus Cyamopsis tetragonolobus (guar gum), Trametes versicolor, Cladosiphon okamuranus Tokida, Undaria pinnatifida, mushrooms, seaweeds, yeasts, brown algae, Agave Nectar, brown seaweed, fermentable fiber, cereal, sea cucumber, agave, artichokes, asparagus, leeks, garlic, onions, rye, barley kernels, wheat, pears, apples, guavas, quince, plums, gooseberries, oranges and other citrus fruits. 10 . The composition of claim 1 , wherein the polyphenolic compounds are enriched from a plant species selected from the group consisting of or a combination thereof Melissa officinalis, Momordica balsamina, Mentha piperita, Perilla frutescens, Salvia officinalis, Teucrium scorodonia, Sanicula europaea, Coleus blumei, Thymus spp Hyptis verticillata, Lithospermum erythrorhizon, hornwort Anthoceros agrestis, Piper longum Linn, Coptis chinensis Franch, Angelica sinensis (Oliv.) Diels, Toxicodendron vernicifluum, Glycyrrhiza glabra, Glycyrrhiza uralensis, Curcuma longa, Salvia Rosmarinus, Rosmarinus officinalis, Zingiber officinalis, Polygala tenuifolia, Humulus lupulus, Lonicera Japonica, Salvia officinalis L., Centella asiatica, Boswellia carteri, Mentha longifolia, Picea crassifolia, Citrus nobilis Lour, Citrus aurantium L. Camellia sinensis L. Pueraria mirifica, Pueraria lobata, Glycine max, Capsicum species, Fallopia japonica, tea, tomato, cruciferous vegetables, grapes, blueberries, raspberries, mulberries, apple, chili peppers. 11 . The composition of claim 1 , wherein the polyphenolic compounds comprise Rosmarinic acid, conjugated catechins such as EGCG, ECG, epigallocatechin, oroxylin, Kaempferol, genistein, quercetin, Butein, Luteolin, chrysin, Apigenin, curcumin, resveratrol, capsaicin, glomeratose A, 6-shogaol, gingerol, berberine, Piperine or a combination thereof. 12 . The composition of claim 1 , wherein the polysaccharides and polyphenols are enriched from a plant part or a fungus selected from the group consisting of leaves, bark, trunk, trunk bark, stem, stem bark, twigs, tubers, root, rhizome, root bark, bark surface, young shoots, seed, fruit, fruitbody, mushroom, androecium, gynoecium, calyx, stamen, petal, sepal, carpel (pistil), flower, or any combination thereof. 13 . The composition of claim 1 , wherein the Aloe extract, the Poria extract and the Rosemary extract in the composition are extracted with any suitable solvent, including supercritical fluid of CO 2 , water, methanol, ethanol, acetone, alcohol, a water-mixed solvent or a combination thereof. 14 . The composition of claim 1 , wherein the polysaccharides are enriched individually and/or in combination by solvent precipitation, ultrafiltration, enzyme digestion, column chromatograph with silica gel, XAD, HP20, LH20, C-18, alumina oxide, polyamide, CG161, and size exclusion column resins. 15 . The composition of claim 1 , wherein one or more polyphenols are enriched individually or in combination by solvent partition, precipitation, distillation, evaporation, ultrafiltration, column chromatograph with silica gel, XAD, HP20, LH2O, C-18, alumina oxide, polyamide, size exclusion column and CG161 resins. 16 . The composition of claim 1 , wherein the composition further comprises a pharmaceutically or nutraceutically acceptable active, adjuvant, carrier, diluent, or excipient, and wherein the pharmaceutical or nutraceutical formulation comprises from about 0.1 weight percent (wt %) to about 99.9 wt % of active compounds. 17 . The composition of claim 16 , wherein the active, adjuvant, excipient or carrier comprises Cannabis sativa oil or CBD/THC, turmeric extract or curcumin, terminalia extract, willow bark extract, Devil's claw root extract, cayenne pepper extract or capsaicin, Prickly Ash bark extract, philodendra bark extract, hop extract, Boswellia extract, rose hips extract, green tea extract, Sophora extract, Mentha or Peppermint extract, ginger or black ginger extract, green tea or grape seed polyphenols, Omega-3 or Omega-6 Fatty Acids, fish oil, Krill oil, gamma-linolenic acid, citrus bioflavonoids, Acerola concentrate, astaxanthin, pycnogenol, vitamin C, vitamin D, vitamin E, vitamin K, vitamin B, vitamin A, L-lysine, calcium, manganese, zinc, mineral amino acid chelate(s), amino acid(s), boron and boron glycinate, silica, probiotics, Camphor, Menthol, calcium-based salts, silica, histidine, copper gluconate, CMC, maltodextrin, beta-cyclodextrin, cellulose, dextrose, saline, water, oil, shark and bovine cartilage, or a combination thereof. 18 . The composition of claim 1 , wherein the composition is formulated as a tablet, hard capsule, soft gel capsule, powder, or granule, compressed tablet, pill, gummy, chewing gum, sashay, wafer, bar, or liquid form, tincture, aerial spread, semi solid, semi liquid, solution, emulsion, cream, lotion, ointment, gel base or like form. 19 . A method for treating, managing, promoting regulation of immunity homeostasis in a mammal, comprising administering an effective amount of a composition from 0.01 mg/kg to 500 mg/kg body weight of the mammal. 20 . The method of claim 19 , wherein the composition comprises a combination of an Aloe extract enriched for one or more polysaccharides; a Poria extract enriched for one or

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022016196A1 cover?
Compositions used and methods are disclosed for regulation of immunity homeostasis including a combination of an Aloe extract enriched for one or more polysaccharides; a Poria extract enriched for one or more polysaccharides; and a Rosemary extract enriched for one or more polyphenolic compounds. Compositions for maintenance of immunity homeostasis by regulating HMGB1, comprising a combin…
Who is the assignee on this patent?
Unigen Inc
What technology area does this patent fall under?
Primary CPC classification A61K36/886. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jan 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).